+499.5%
MRNA vs CAPR
+48.7%
+450.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CAPR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.3% | -3.5% | -2.3% |
| 7D | +5.5% | -2.0% | +7.5% | +5.5% |
| 30D | +158.7% | +139.2% | +19.5% | +155.2% |
| 3M | +182.1% | -66.4% | +248.5% | +183.2% |
| 6M | +151.8% | -63.1% | +215.0% | +152.4% |
| YTD | +393.6% | -67.4% | +461.0% | +395.3% |
| 1Y | +499.5% | +58.2% | +441.2% | +471.5% |
| All | +499.5% | +48.7% | +450.7% | +471.5% |
Cumulative growth
Daily Returns
Daily percentage return beside CAPR.
Daily Out/Under-Performance
Portfolio return minus CAPR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CAPR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CAPR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling